Harmony Biosciences Holdings (HRMY)

Harmony Biosciences Holdings (HRMY) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $2.1B; returns 1 day +0.3%, 1 week -4.8%, 1 year +22.1%.

Harmony Biosciences Holdings, Inc. (HRMY) is a commercial-stage pharmaceutical company primarily focused on developing and commercializing innovative therapies for patients with rare neurological diseases in the United States.

Groups HRMY belongs to

• Healthcare
• Pharmaceuticals
• Rare Diseases
• Neurological Disorders
• Commercial Stage
• CNS Disorders
• Sleep Apnea
• Commercial Stage Biotech
• Neuroscience
• Biotechnology
• Prader-Willi Syndrome

HRMY financial model: income statement, cash flow and balance sheet